In Singulo Solutions is a life science company that provides biosensing technology for drug development, diagnostics, and quality control.
In Singulo Solutions has raised $1.8M in total funding. The most recent round was Series A. The last funding was announced in February 2024.
In Singulo Solutions's investors include Chalmers Ventures AB.
In Singulo Solutions is headquartered in Stockholm, Sweden.
In Singulo Solutions is a life science company that provides biosensing technology for drug development, diagnostics, and quality control.
In Singulo Solutions is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"In Singulo Solutions — Funding & Investors." VCBacked, February 20, 2024, https://www.vcbacked.co/company/in-singulo-solutions. Accessed October 29, 2026.
VCBacked. (2024). In Singulo Solutions — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/in-singulo-solutions
{{cite web |title=In Singulo Solutions — Funding & Investors |url=https://www.vcbacked.co/company/in-singulo-solutions |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated